Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer's disease patients - PubMed

Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer's disease patients

Egemen Savaskan et al. J Pineal Res. 2002 Jan.

Abstract

The pineal secretory product melatonin has, in addition to regulating retinal, circadian and vascular functions, neuroprotective effects. Blood melatonin levels are often decreased in Alzheimer's disease (AD), a progressively disabling neurodegenerative disorder. In this study we provide the first immunohistochemical evidence for the localization of melatonin 1a-receptor (MT(1)) in aged human hippocampus and a comparison of AD cases. MT(1) was localized to pyramidal neurons in the hippocampal cornu ammonis (CA)1-4 subfields. There was a distinct increase in staining intensity in all AD cases indicating an up-regulation of the receptor, possibly as a compensatory response to impaired melatonin levels in order to augment melatonin's neuroprotective effects.

Similar articles

• Cerebrovascular melatonin MT1-receptor alterations in patients with Alzheimer's disease.

  Savaskan E, Olivieri G, Brydon L, Jockers R, Kräuchi K, Wirz-Justice A, Müller-Spahn F. Savaskan E, et al. Neurosci Lett. 2001 Jul 27;308(1):9-12. doi: 10.1016/s0304-3940(01)01967-x. Neurosci Lett. 2001. PMID: 11445273

• The MT2 melatonin receptor subtype is present in human retina and decreases in Alzheimer's disease.

  Savaskan E, Jockers R, Ayoub M, Angeloni D, Fraschini F, Flammer J, Eckert A, Müller-Spahn F, Meyer P. Savaskan E, et al. Curr Alzheimer Res. 2007 Feb;4(1):47-51. doi: 10.2174/156720507779939823. Curr Alzheimer Res. 2007. PMID: 17316165

• Distribution of melatonin MT1 receptor immunoreactivity in human retina.

  Savaskan E, Wirz-Justice A, Olivieri G, Pache M, Kräuchi K, Brydon L, Jockers R, Müller-Spahn F, Meyer P. Savaskan E, et al. J Histochem Cytochem. 2002 Apr;50(4):519-26. doi: 10.1177/002215540205000408. J Histochem Cytochem. 2002. PMID: 11897804

• Melatonin in Synaptic Impairments of Alzheimer's Disease.

  Shi Y, Fang YY, Wei YP, Jiang Q, Zeng P, Tang N, Lu Y, Tian Q. Shi Y, et al. J Alzheimers Dis. 2018;63(3):911-926. doi: 10.3233/JAD-171178. J Alzheimers Dis. 2018. PMID: 29710712 Review.

• Melatonin receptors and their regulation: biochemical and structural mechanisms.

  Witt-Enderby PA, Bennett J, Jarzynka MJ, Firestine S, Melan MA. Witt-Enderby PA, et al. Life Sci. 2003 Apr 4;72(20):2183-98. doi: 10.1016/s0024-3205(03)00098-5. Life Sci. 2003. PMID: 12628439 Review.

Cited by

• The pattern of melatonin receptor expression in the brain may influence antidepressant treatment.

  Hirsch-Rodriguez E, Imbesi M, Manev R, Uz T, Manev H. Hirsch-Rodriguez E, et al. Med Hypotheses. 2007;69(1):120-4. doi: 10.1016/j.mehy.2006.11.012. Epub 2007 Jan 2. Med Hypotheses. 2007. PMID: 17197111 Free PMC article.

• Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?

  Jockers R, Maurice P, Boutin JA, Delagrange P. Jockers R, et al. Br J Pharmacol. 2008 Jul;154(6):1182-95. doi: 10.1038/bjp.2008.184. Epub 2008 May 19. Br J Pharmacol. 2008. PMID: 18493248 Free PMC article. Review.

• MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective.

  Liu J, Clough SJ, Hutchinson AJ, Adamah-Biassi EB, Popovska-Gorevski M, Dubocovich ML. Liu J, et al. Annu Rev Pharmacol Toxicol. 2016;56:361-83. doi: 10.1146/annurev-pharmtox-010814-124742. Epub 2015 Oct 23. Annu Rev Pharmacol Toxicol. 2016. PMID: 26514204 Free PMC article. Review.

• Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction.

  Hardeland R. Hardeland R. ScientificWorldJournal. 2012;2012:640389. doi: 10.1100/2012/640389. Epub 2012 May 2. ScientificWorldJournal. 2012. PMID: 22629173 Free PMC article. Review.

• Drug- and region-specific effects of protracted antidepressant and cocaine treatment on the content of melatonin MT(1) and MT(2) receptor mRNA in the mouse brain.

  Imbesi M, Uz T, Yildiz S, Arslan AD, Manev H. Imbesi M, et al. Int J Neuroprot Neuroregener. 2006;2(3):185-9. Int J Neuroprot Neuroregener. 2006. PMID: 18389085 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • BioCyc